Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

12 trials with published results (44%)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

7.4%

2 terminated out of 27 trials

Success Rate

92.3%

+5.8% vs benchmark

Late-Stage Pipeline

59%

16 trials in Phase 3/4

Results Transparency

50%

12 of 24 completed with results

Key Signals

12 with results92% success

Data Visualizations

Phase Distribution

26Total
Not Applicable (4)
P 2 (6)
P 3 (8)
P 4 (8)

Trial Status

Completed24
Terminated2
Withdrawn1

Trial Success Rate

92.3%

Benchmark: 86.5%

Based on 24 completed trials

Clinical Trials (27)

Showing 20 of 20 trials
NCT03981822Phase 2Completed

A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts

NCT03487549Phase 2Completed

Cantharidin and Occlusion in Verruca Epithelium

NCT05608382Not ApplicableCompletedPrimary

Effect of an Antiseptic Solution on the Skin Microbiome

NCT04485676Completed

Dalbavancin in Real Clinical Practice in Spain

NCT03643952Phase 2Completed

Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)

NCT00865280Phase 3TerminatedPrimary

Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

NCT00761215Phase 2CompletedPrimary

Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections

NCT02276482Phase 3CompletedPrimary

Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)

NCT02600871Phase 4CompletedPrimary

Skin and Soft Tissue Infection (SSTI) Study

NCT01967225Phase 3CompletedPrimary

Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections

NCT00711802Phase 4CompletedPrimary

Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections

NCT00679302Phase 4CompletedPrimary

Utility of Trimethoprim-sulfamethoxazole Use in Skin Abscess Management

NCT00198679Phase 4CompletedPrimary

Effect of Chlorhexidine Skin Cleansing on Skin Flora

NCT02582203Phase 4CompletedPrimary

Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA

NCT00990392Not ApplicableWithdrawn

Topical Antibiotics for Prevention of Intensive Care Unit (ICU) Central Line Infections

NCT00785200Not ApplicableCompleted

MRSA Colonization and Control in the Dallas County Jail

NCT00228410Phase 3CompletedPrimary

Study Comparing Tigecycline and Vancomycin With Aztreonam in Complicated Skin and Skin Structure Infections

NCT00343135Phase 4CompletedPrimary

AUGMENTIN 1gm In Skin And Soft Tissue Infection

NCT00388310Not ApplicableCompletedPrimary

Effective Antibiotic Treatment of MRSA

NCT00488345Phase 2Completed

Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age

Scroll to load more

Research Network

Activity Timeline